{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:34:29Z","timestamp":1766086469988},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Biochemical Sciences"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.tibs.2008.01.004","type":"journal-article","created":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T05:50:57Z","timestamp":1205905857000},"page":"151-155","source":"Crossref","is-referenced-by-count":20,"title":["A new take on prions: preventing Alzheimer's disease"],"prefix":"10.1016","volume":"33","author":[{"given":"Nigel M.","family":"Hooper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibs.2008.01.004_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jalz.2007.02.001","article-title":"An estimate of the total worldwide societal costs of dementia in 2005","volume":"3","author":"Wimo","year":"2007","journal-title":"Alzheimer's & Dementia"},{"key":"10.1016\/j.tibs.2008.01.004_bib2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nm0706-770","article-title":"Public funding for Alzheimer disease research in the United States","volume":"12","author":"Hodes","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.tibs.2008.01.004_bib3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1126\/science.1132813","article-title":"100 years and counting: prospects for defeating Alzheimer's disease","volume":"314","author":"Roberson","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tibs.2008.01.004_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/35052063","article-title":"Prions: health scare and biological challenge","volume":"2","author":"Aguzzi","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tibs.2008.01.004_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.tibs.2008.01.004_bib6","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0140-6736(06)69835-8","article-title":"Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report","volume":"368","author":"Wroe","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.tibs.2008.01.004_bib7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.tibs.2008.01.004_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1471-4914(03)00069-8","article-title":"Is loss of function of the prion protein the cause of prion disorders?","volume":"9","author":"Hetz","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tibs.2008.01.004_bib9","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.283.13.1689-a","article-title":"Early-onset familial Alzheimer disease with coexisting beta-amyloid and prion pathology","volume":"283","author":"Leuba","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.tibs.2008.01.004_bib10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1440-1789.2003.00513.x","article-title":"Coexistence of CJD and Alzheimer's disease: an autopsy case showing typical clinical features of CJD","volume":"24","author":"Tsuchiya","year":"2004","journal-title":"Neuropathology"},{"key":"10.1016\/j.tibs.2008.01.004_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ana.10507","article-title":"PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease","volume":"53","author":"Dermaut","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tibs.2008.01.004_bib12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/01.WNL.0000130198.72589.69","article-title":"Prion protein codon 129 polymorphism and risk of Alzheimer disease","volume":"63","author":"Riemenschneider","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.tibs.2008.01.004_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1212\/01.WNL.0000103290.74549.DC","article-title":"Polymorphisms within the prion (PrP) and prion-like protein (Doppel) genes in AD","volume":"62","author":"Golanska","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.tibs.2008.01.004_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tibs.2008.01.004_bib15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0166-2236(02)02263-4","article-title":"Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators","volume":"25","author":"Checler","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tibs.2008.01.004_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.tibs.2006.06.006","article-title":"Delineating common molecular mechanisms in Alzheimer's and prion diseases","volume":"31","author":"Barnham","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tibs.2008.01.004_bib17","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1073\/pnas.0609621104","article-title":"Cellular prion protein regulates \u03b2-secretase cleavage of the Alzheimer's amyloid precursor protein","volume":"104","author":"Parkin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibs.2008.01.004_bib18","doi-asserted-by":"crossref","first-page":"13461","DOI":"10.1073\/pnas.0503689102","article-title":"Neuronal sorting protein-related receptor sorLA\/LR11 regulates processing of the amyloid precursor protein","volume":"102","author":"Andersen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibs.2008.01.004_bib19","doi-asserted-by":"crossref","first-page":"22707","DOI":"10.1074\/jbc.M611050200","article-title":"Rodent A\u03b2 modulates the solubility and distribution of amyloid deposits in transgenic mice","volume":"282","author":"Jankowsky","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tibs.2008.01.004_bib20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.neurobiolaging.2004.10.004","article-title":"Prion protein (PrPc) promotes \u03b2-amyloid plaque formation","volume":"26","author":"Schwarze-Eicker","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tibs.2008.01.004_bib21","doi-asserted-by":"crossref","first-page":"18421","DOI":"10.1074\/jbc.M110406200","article-title":"Identification of the heparan sulfate binding sites in the cellular prion protein","volume":"277","author":"Warner","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tibs.2008.01.004_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1042\/bj20020773","article-title":"Cell-surface prion protein interacts with glycosaminoglycans","volume":"368","author":"Pan","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.tibs.2008.01.004_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/09687860500496417","article-title":"The involvement of lipid rafts in Alzheimer's disease","volume":"23","author":"Cordy","year":"2006","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.tibs.2008.01.004_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/09687860500449994","article-title":"The prion protein and lipid rafts","volume":"23","author":"Taylor","year":"2006","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.tibs.2008.01.004_bib25","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1242\/jcs.02627","article-title":"Assigning functions to distinct regions of the N-terminus of the prion protein that are involved in its copper-stimulated, clathrin-dependent endocytosis","volume":"118","author":"Taylor","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.tibs.2008.01.004_bib26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/emboj\/20.4.703","article-title":"Membrane topology influences N-glycosylation of the prion protein","volume":"20","author":"Walmsley","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.tibs.2008.01.004_bib27","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1083\/jcb.200404149","article-title":"Neuronal membrane cholesterol loss enhances amyloid peptide generation","volume":"167","author":"Abad-Rodriguez","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tibs.2008.01.004_bib28","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1369\/jhc.4A6551.2005","article-title":"Expression of cellular prion protein in the frontal and occipital lobe in Alzheimer's disease, diffuse Lewy body disease, and in normal brain: an immunohistochemical study","volume":"53","author":"Rezaie","year":"2005","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.tibs.2008.01.004_bib29","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archneur.59.9.1381","article-title":"\u03b2-secretase protein and activity are increased in the neocortex in Alzheimer disease","volume":"59","author":"Fukumoto","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tibs.2008.01.004_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nm0103-3","article-title":"Elevated \u03b2-secretase expression and enzymatic activity detected in sporadic Alzheimer disease","volume":"9","author":"Yang","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.tibs.2008.01.004_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1086\/302702","article-title":"High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes","volume":"66","author":"Finckh","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tibs.2008.01.004_bib32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1006\/bbrc.1993.1447","article-title":"An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques","volume":"192","author":"Kitamoto","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tibs.2008.01.004_bib33","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1073\/pnas.93.2.744","article-title":"Vascular variant of prion protein cerebral amyloidosis with tau- positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP","volume":"93","author":"Ghetti","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibs.2008.01.004_bib34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/356577a0","article-title":"Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein","volume":"356","author":"Bueler","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.tibs.2008.01.004_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02780662","article-title":"129\/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal","volume":"8","author":"Manson","year":"1994","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tibs.2008.01.004_bib36","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1474-4422(06)70413-6","article-title":"Predicting susceptibility and incubation time of human-to-human transmission of vCJD","volume":"5","author":"Bishop","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tibs.2008.01.004_bib37","doi-asserted-by":"crossref","first-page":"11265","DOI":"10.1074\/jbc.M008734200","article-title":"In vivo conversion of cellular prion protein to pathogenic isoforms, as monitored by conformation-specific antibodies","volume":"276","author":"Yokoyama","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tibs.2008.01.004_bib38","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibs.2008.01.004_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0169-328X(95)00175-R","article-title":"Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene","volume":"34","author":"Krasemann","year":"1995","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.tibs.2008.01.004_bib40","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.279.5352.827","article-title":"A transmembrane form of the prion protein in neurodegenerative disease","volume":"279","author":"Hegde","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.tibs.2008.01.004_bib41","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nrd1525","article-title":"Prion diseases\u2013close to effective therapy?","volume":"3","author":"Cashman","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tibs.2008.01.004_bib42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrn1584","article-title":"Rational targeting for prion therapeutics","volume":"6","author":"Mallucci","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tibs.2008.01.004_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/emboj\/21.3.202","article-title":"Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration","volume":"21","author":"Mallucci","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.tibs.2008.01.004_bib44","doi-asserted-by":"crossref","first-page":"18524","DOI":"10.1074\/jbc.M210723200","article-title":"Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells","volume":"278","author":"Gilch","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tibs.2008.01.004_bib45","doi-asserted-by":"crossref","first-page":"11247","DOI":"10.1074\/jbc.M407006200","article-title":"Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells","volume":"280","author":"Feraudet","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tibs.2008.01.004_bib46","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1126\/science.1063093","article-title":"Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies","volume":"294","author":"Heppner","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.tibs.2008.01.004_bib47","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nature01457","article-title":"Monoclonal antibodies inhibit prion replication and delay the development of prion disease","volume":"422","author":"White","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.tibs.2008.01.004_bib48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.emboj.7600061","article-title":"Take five-BACE and the \u03b3-secretase quartet conduct Alzheimer's amyloid \u03b2-peptide generation","volume":"23","author":"Haass","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.tibs.2008.01.004_bib49","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1586\/14737175.6.5.695","article-title":"Emerging therapeutics for Alzheimer's disease","volume":"6","author":"Vardy","year":"2006","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.tibs.2008.01.004_bib50","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jnr.10737","article-title":"ADAMs family members as amyloid precursor protein \u03b1-secretases","volume":"74","author":"Allinson","year":"2003","journal-title":"J. Neurosci. Res."}],"container-title":["Trends in Biochemical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968000408000467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968000408000467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T22:54:16Z","timestamp":1546210456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968000408000467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0968000408000467"],"URL":"https:\/\/doi.org\/10.1016\/j.tibs.2008.01.004","relation":{},"ISSN":["0968-0004"],"issn-type":[{"value":"0968-0004","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}